Security key
78667J108
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)
CUSIP: 78667J108
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
- Shares outstanding
- 62,650,155
- Total 13F shares
- 53,660,582
- Share change
- -857,937
- Total reported value
- $3,277,403,116
- Put/Call ratio
- 37%
- Price per share
- $61.12
- Number of holders
- 224
- Value change
- -$18,817,366
- Number of buys
- 106
- Number of sells
- 97
Report period
Q3 2020
Institutions
224
Top holders
10
SAGE full security history
Newer quarter: Q4 2020
Previous quarter: Q2 2020
Sage Therapeutics, Inc. SEC filings
Sage Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 78667J108
Recent filing periods:
Top shareholders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
12%
|
7,787,672
|
$323,811,000 | — | 30 Jun 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.6%
|
4,733,032
|
$196,799,000 | — | 30 Jun 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.1%
|
3,185,313
|
$132,447,000 | — | 30 Jun 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.5%
|
2,819,052
|
$117,216,000 | — | 30 Jun 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
3.4%
|
2,122,156
|
$88,239,000 | — | 30 Jun 2020 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
2,117,336
|
$88,039,000 | — | 30 Jun 2020 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
3.4%
|
2,102,368
|
$87,416,000 | — | 30 Jun 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.8%
|
1,763,613
|
$73,331,000 | — | 30 Jun 2020 | |
| Invesco Ltd. |
13F
|
Company |
2.8%
|
1,738,408
|
$72,282,000 | — | 30 Jun 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.3%
|
1,459,676
|
$60,695,000 | — | 30 Jun 2020 | |
| Bellevue Group AG |
13F
|
Company |
2.3%
|
1,415,504
|
$58,856,000 | — | 30 Jun 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.2%
|
1,390,302
|
$57,809,000 | — | 30 Jun 2020 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.9%
|
1,215,429
|
$50,538,000 | — | 30 Jun 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
1.7%
|
1,094,000
|
$45,489,000 | — | 30 Jun 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.6%
|
981,106
|
$40,794,000 | — | 30 Jun 2020 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
850,000
|
$35,343,000 | — | 30 Jun 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
812,785
|
$33,795,000 | — | 30 Jun 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.2%
|
731,999
|
$30,437,000 | — | 30 Jun 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.99%
|
620,400
|
$25,796,000 | — | 30 Jun 2020 | |
| Palo Alto Investors LP |
13F
|
Company |
0.92%
|
575,200
|
$23,917,000 | — | 30 Jun 2020 | |
| NORGES BANK |
13F
|
Company |
0.92%
|
573,578
|
$23,849,000 | — | 30 Jun 2020 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.9%
|
562,457
|
$23,387,000 | — | 30 Jun 2020 | |
| Camber Capital Management LP |
13F
|
Company |
0.84%
|
525,000
|
$21,830,000 | — | 30 Jun 2020 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
0.8%
|
499,100
|
$20,753,000 | — | 30 Jun 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.7%
|
440,846
|
$18,330,376 | — | 30 Jun 2020 | |
| Capital International Investors |
13F
|
Company |
0.69%
|
435,311
|
$18,100,000 | — | 30 Jun 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.6%
|
377,279
|
$15,687,000 | — | 30 Jun 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.59%
|
372,616
|
$15,497,000 | — | 30 Jun 2020 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.55%
|
347,353
|
$14,443,000 | — | 30 Jun 2020 | |
| Vivo Capital, LLC |
13F
|
Company |
0.55%
|
343,179
|
$14,269,000 | — | 30 Jun 2020 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.53%
|
333,918
|
$13,948,000 | — | 30 Jun 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.51%
|
316,695
|
$13,168,000 | — | 30 Jun 2020 | |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. |
13F
|
Company |
0.5%
|
310,814
|
$12,923,646 | — | 30 Jun 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.49%
|
305,422
|
$12,699,000 | — | 30 Jun 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.48%
|
301,216
|
$12,525,000 | — | 30 Jun 2020 | |
| Woodline Partners LP |
13F
|
Company |
0.46%
|
287,943
|
$11,973,000 | — | 30 Jun 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.46%
|
285,800
|
$11,884,000 | — | 30 Jun 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.45%
|
280,435
|
$11,661,000 | — | 30 Jun 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.41%
|
256,275
|
$10,656,000 | — | 30 Jun 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.4%
|
252,916
|
$10,517,000 | — | 30 Jun 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.38%
|
238,679
|
$11,302,000 | — | 30 Jun 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.37%
|
234,000
|
$9,730,000 | — | 30 Jun 2020 | |
| AXA S.A. |
13F
|
Company |
0.36%
|
223,272
|
$9,284,000 | — | 30 Jun 2020 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.35%
|
219,765
|
$9,138,000 | — | 30 Jun 2020 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.35%
|
218,238
|
$9,074,000 | — | 30 Jun 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.35%
|
217,555
|
$9,046,000 | — | 30 Jun 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.33%
|
206,900
|
$8,603,000 | — | 30 Jun 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.32%
|
201,151
|
$8,364,000 | — | 30 Jun 2020 | |
| Asymmetry Capital Management, L.P. |
13F
|
Company |
0.31%
|
197,249
|
$8,202,000 | — | 30 Jun 2020 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.31%
|
195,000
|
$8,108,000 | — | 30 Jun 2020 |
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q3 2020
As of 30 Sep 2020,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
224 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,660,582 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, D. E. Shaw & Co., Inc., GREAT POINT PARTNERS LLC, JANUS HENDERSON GROUP PLC, Bellevue Group AG, JPMORGAN CHASE & CO, and Invesco Ltd..
This page lists
224
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
207
Q3 2020 holders
224
Holder diff
17
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.